Caris & Co. Resumes Coverage on Emergent BioSolutions (EBS) at Buy
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.59 +2.23%
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Caris & Co. resumes coverage on Emergent BioSolutions (NYSE: EBS) with a Buy. PT $24.00.
For an analyst ratings summary and ratings history on Emergent BioSolutions click here. For more ratings news on Emergent BioSolutions click here.
Shares of Emergent BioSolutions closed at $16.53 yesterday.
For an analyst ratings summary and ratings history on Emergent BioSolutions click here. For more ratings news on Emergent BioSolutions click here.
Shares of Emergent BioSolutions closed at $16.53 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emergent BioSolutions (EBS) PT Lowered to $10 at H.C. Wainwright
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- JPMorgan Resumes SanDisk (SNDK) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
